Serena Williams weighs in on weight loss drugs and stigma

The article analyzes how Williams's disclosure intersects with public perceptions of GLP-1 medications and access.

Serena Williams weighs in on weight loss drugs and stigma

Serena Williams discussed her use of weight loss medication as part of her goal to reach a healthy weight after the birth of her second child. In a Today Show interview she said she wanted to find a weight she felt comfortable with and that her training remains a big part of the effort. The article notes that other celebrities such as Oprah Winfrey and Whoopi Goldberg have spoken openly about GLP-1 medications, showing the drugs have entered mainstream conversations.

Experts like Dr Claire Madigan warn that elite athletes can struggle to lose weight and that changes in behavior are needed after sport ends. The piece adds that Williams credited diet and physical activity alongside the drug and highlights the importance of discussing possible side effects, which can include stomach issues and, rarely, gallbladder or kidney problems. Williams says she experienced no side effects and is seeing benefits as she trains for a half marathon.

The moment draws attention to how public figures frame medical choices. When a famous athlete talks about a drug, it can reduce stigma but also tilt the discussion toward wealth and access. The story shows how messaging around obesity drugs sits at the intersection of health and image.

Policy and health equity are at stake. If GLP-1s are expensive, many people may struggle to access them and rely on lifestyle changes instead. The piece invites a broader conversation about cost, safety, and patient education that goes beyond celebrity anecdotes.

Highlights

The conversation on weight, medicine, and fairness continues.